applications of viruses for cancer therapy
Applications of Viruses for Cancer Therapy
$265.00 Original price was: $265.00.$4.99Current price is: $4.99. Add to cart
Sale!

Applications of Viruses for Cancer Therapy

Original price was: $265.00.Current price is: $4.99.

-98%

Flash Sale: Any ebook for just 4.99 USD only

  • Pay with Any Debit/Credit Card
  • Affordable Prices for Readers
Guaranteed Safe Checkout

The Engineered Infection: Applications of Viruses for Cancer Therapy

For a century, humanity has viewed viruses purely as enemies. In modern oncology, they are being reprogrammed into elite, microscopic assassins. Applications of Viruses for Cancer Therapy is a fiercely advanced, highly technical virology and bioengineering manual detailing the exact mechanics of oncolytic viruses. This volume provides the precise genetic blueprints for weaponizing a virus to hunt and destroy human cancer cells.

Mastering the Oncolytic Mechanism

The core philosophy of this text is viral specificity. The authors aggressively detail the genetic reprogramming of the pathogen. It dictates exactly how bioengineers take a herpes virus, delete the specific genes that allow it to infect normal brain tissue, and inject it directly into a glioblastoma, where the virus rapidly replicates until the cancer cell literally bursts open (lysis), spreading the infection exclusively to other cancer cells.

Navigating the Immunological Awakening

The book provides a masterclass in secondary immune activation. It dictates the exact biological pathways of the viral wake-up call. It rigorously explores how an oncolytic virus not only physically destroys the tumor, but also violently spills the tumor’s hidden antigens into the bloodstream, acting as a massive flare gun that alerts the patient’s own immune system to attack any remaining metastatic disease.

Frequently Asked Questions (FAQs)

Is this a clinical manual detailing standard hospital chemotherapy?
No, it is a highly advanced *molecular virology, bioengineering, and experimental oncology textbook* focused entirely on the development and deployment of viral therapies.

Who is the primary audience?
It is the absolute, mandatory benchtop reference for Molecular Biologists, Tumor Immunologists, Virologists, and Translational Researchers.